May 14, 2013
Merus Labs International Inc. Announces Second Quarter Results for Fiscal 2013
Merus Labs International Inc. Announces Second Quarter Results for Fiscal 2013
April 23, 2013
Merus Provides Enablex Operational Update
Merus Provides Enablex Operational Update
March 29, 2013
Merus Announces Annual General Meeting Results
Merus Announces Annual General Meeting Results
March 13, 2013
Merus to Present at Roth Capital Partners 25th Conference
Merus to Present at Roth Capital Partners 25th Conference
February 27, 2013
Merus to Present at Cowen and Company Annual Health Care Conference
Merus to Present at Cowen and Company Annual Health Care Conference
ENABLEX®/ EMSELEX®
Enablex® (darifenacin) is a prescription medicine used in adults to treat the following symptoms of overactive bladder: a strong need to urinate with leaking or wetting accidents (urge urinary incontinence), a strong need to urinate right away (urgency), and having to urinate often (urinary frequency)... [more]
Enablex® (darifenacin) is a prescription medicine used in adults to treat the following symptoms of overactive bladder: a strong need to urinate with leaking or wetting accidents (urge urinary incontinence), a strong need to urinate right away (urgency), and having to urinate often (urinary frequency)... [more]
VANCOCIN® capsules
Clostridium difficile infection (CDI) causes watery or mucousy diarrhea, lower abdominal pain and systemic symptoms such as fever, anorexia, nausea and malaise when mildly symptomatic, and life-threatening toxic megacolon when severe... [more]
Symbol: MSLI
Last:
Change:
Date:
Time:
Last:
Change:
Date:
Time:
Symbol: MSL
Last:
Change:
Date:
Time:
Last:
Change:
Date:
Time:
Quotes are delayed at least 15 minutes.
Copyright © 2012 Merus Labs Inc. All Rights Reserved.